Rebound Therapeutics
AcquiredIrvine, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into Rebound Therapeutics
Acquired by Integra LifeSciences Holdings Corporation September 2019 · terms undisclosed · source ↗
Rebound Therapeutics developed single-use minimally invasive surgical devices with integrated cameras, optics, and illumination for neurosurgical visualization and treatment, such as accessing and removing intracranial hematomas.
Founders & leadership
TP
Tracy PearsonExecutive
JJ
Jeffrey J. ValkoExecutive
MR
Michael R. HensonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$20.3M disclosed across 2 rounds · 2015–2017
▶$16.5MraisedJul 2017 · 49 investors · Other TechnologyRule 506(b)
▶$16.5MraisedJul 2017 · 49 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tracy PearsonExecutive Officer
- Michael R. HensonExecutive Officer, Director
- Jeffrey J. ValkoExecutive Officer, Director
- Offering amount
- $16.5M
- Amount sold
- $16.5M
- Minimum investment
- $5K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.8MraisedDec 2015 · 29 investors · Other TechnologyRule 506(b)
▶$3.8MraisedDec 2015 · 29 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tracy PearsonExecutive Officer
- Michael R. HensonExecutive Officer, Director
- Jeffrey J. ValkoExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.8M
- Minimum investment
- $10K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Rebound Therapeutics do?
- Rebound Therapeutics developed single-use minimally invasive surgical devices with integrated cameras, optics, and illumination for neurosurgical visualization and treatment, such as accessing and removing intracranial hematomas.
- Who are Rebound Therapeutics's investors?
- Rebound Therapeutics's investors include 415 Capital.
- How much funding has Rebound Therapeutics raised?
- Rebound Therapeutics has disclosed $20.3M raised across 2 rounds.
- Where is Rebound Therapeutics headquartered?
- Rebound Therapeutics is headquartered in Irvine, US.